An alliance of 32 healthcare facilities and medical research institutes was yesterday founded to bolster the nation’s clinical trial capabilities.
Taiwan’s medical techniques are among the best in the world, but its clinical trials lag behind in scale, the Taiwan Alliance of Clinical Trial Centers said.
A “clinical national team” has been set up to improve efficiency and cooperation, the alliance said.
Photo: CNA
Cofounded by Taipei Medical University (TMU) and three affiliated hospitals — TMU Hospital, Shuang Ho Hospital and Wanfang Hospital — and Taichung Veterans General Hospital, the alliance aims to turn Taiwan into the Asia-Pacific region’s clinical trial hub, it said.
Taiwan conducts about 300 to 400 clinical trials a year, which is significantly lower than in South Korea or Australia, which hold more than 1,000 clinical trials per year, alliance preparation convener TMU president Wu Mai-szu (吳麥斯) said.
Clinical trials must be conducted under strict ethics and regulations to ensure the safety and efficacy of medical innovation, he said.
Whether high-quality clinical trials can be conducted across several facilities is an important indicator of a country’s medical quality and regulatory maturity, he added.
The alliance is to prioritize six major tasks, including setting a standard Institutional Review Board (IRB) document and strengthening the collaborative-IRB mechanism, creating a clinical trial contract template, and building a database of research project managers and attending physicians.
They also include establishing a national clinical trial participant enrollment platform, cooperating in cultivating clinical trial experts, and promoting an Asia-Pacific strategic alliance and international multicenter collaborations, he said.
“This is an important milestone,” Minister of Health and Welfare Shih Chung-liang (石崇良) said at the launch in Taipei.
The development of new drugs has accelerated in the past few years, and more treatments are being developed through molecular approaches and genomic research, which might induce different responses depending on ethnicity or region, making local trials important, he said.
Countries are pursuing local clinical trials to facilitate public access to drugs after they hit the market, he said.
As large pharmaceutical companies prefer to hold clinical trials in locations that have faster patient recruitment rates, the alliance can serve as a single point of contact and apply universal standards and procedures across hospitals, increasing enrollment efficiency and attracting more global pharmaceutical companies to conduct their clinical trials in Taiwan, the minister said.
“The alliance is not only beneficial for international cooperation, it can also help improve Taiwan’s development of new drugs, generic drugs or biosimilars drugs, by increasing the speed of [clinical trial] patient enrollment,” he said. “I think it is a triple-win strategy that would benefit the industry, patients and local academic research.”
Considering that most countries issue more than five denominations of banknotes, the central bank has decided to redesign all five denominations, the bank said as it prepares for the first major overhaul of the banknotes in more than 24 years. Central bank Governor Yang Chin-lung (楊金龍) is expected to report to the Legislative Yuan today on the bank’s operations and the redesign’s progress. The bank in a report sent to the legislature ahead of today’s meeting said it had commissioned a survey on the public’s preferences. Survey results showed that NT$100 and NT$1,000 banknotes are the most commonly used, while NT$200 and NT$2,000
The Centers for Disease Control (CDC) yesterday reported the first case of a new COVID-19 subvariant — BA.3.2 — in a 10-year-old Singaporean girl who had a fever upon arrival in Taiwan and tested positive for the disease. The girl left Taiwan on March 20 and the case did not have a direct impact on the local community, it said. The WHO added the BA.3.2 strain to its list of Variants Under Monitoring in December last year, but this was the first imported case of the COVID-19 variant in Taiwan, CDC Deputy Director-General Lin Ming-cheng (林明誠) said. The girl arrived in Taiwan on
ANNUAL EVENT: Two massive Pokemon balloons are to be set up in Daan Park, with an event zone operating from 10am to 6pm This year’s Taipei Floral Picnic is to be held at Daan Park today and tomorrow, featuring an exclusive Pokemon Go event, a themed food market, a coffee rave picnic area and stage performances, the Taipei Department of Information and Tourism said yesterday. Two massive Pokemon balloons are to be set up in the park as attractions, with an exclusive event zone operating from 10am to 6pm, it said. Participants who complete designated tasks on-site would have a chance to receive limited-edition souvenirs, it added. People could also try the newly launched game Pokemon Pokopia in the trial area, the department said. Three PokeStops are
South Korea is planning to revise its controversial electronic arrival card, a step Taiwanese officials said prompted them to hold off on planned retaliatory measures, a South Korean media report said yesterday. A Yonhap News Agency report said that the South Korean Ministry of Foreign Affairs is planning to remove the “previous departure place” and “next destination” fields from its e-arrival card system. The plan, reached after interagency consultations, is under review and aims to simplify entry procedures and align the electronic form with the paper version, a South Korean ministry official said. The fields — which appeared only on the electronic form
RSS